Ivosidenib
Back to searchMolecule Structure
Scientific Name
Ivosidenib
Description of the Drug
Ivosidenib is an isocitrate dehydrogenase-1 inhibitor used to treat acute myeloid leukemia and cholangiocarcinoma in adults with a susceptible IDH1 mutation.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB14568
http://www.drugbank.ca/drugs/DB14568
Brand Name(s)
Tibsovo
Company Owner(s)
Servier Pharmaceuticals Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Isocitrate dehydrogenase [NADP] cytoplasmic | SINGLE PROTEIN | INHIBITOR | CHEMBL2007625 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL15122512 | |
| DrugBank | DB14568 | |
| PubChem | 71657455 | |
| BindingDB | 363689 | |
| DrugCentral | 5292 | |
| ChemicalBook | CB32738771 | |
| Guide to Pharmacology | 9217 | |
| rxnorm | IVOSIDENIB | TIBSOVO |
| ChEBI | 145430 | |
| ZINC | ZINC000205136523 |
